Published in J Artif Organs on January 01, 2006
Chitin research revisited. Mar Drugs (2010) 1.23
Chitin-based materials in tissue engineering: applications in soft tissue and epithelial organ. Int J Mol Sci (2011) 1.09
A multilayered scaffold of a chitosan and gelatin hydrogel supported by a PCL core for cardiac tissue engineering. Acta Biomater (2012) 1.04
Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev (2007) 1.03
Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis (2008) 1.00
Journal of Artificial Organs 2006: the year in review. J Artif Organs (2007) 0.88
Chitosan cooperates with mesenchyme-derived factors in regulating salivary gland epithelial morphogenesis. J Cell Mol Med (2008) 0.86
Angiogenic therapy for cardiac repair based on protein delivery systems. Heart Fail Rev (2012) 0.83
Adsorption of Silver Nanoparticles onto Different Surface Structures of Chitin/Chitosan and Correlations with Antimicrobial Activities. Int J Mol Sci (2015) 0.82
Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications. Mar Drugs (2015) 0.81
Application of hydrogels as submucosal fluid cushions for endoscopic mucosal resection and submucosal dissection. J Artif Organs (2015) 0.79
Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature (1962) 3.65
Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem (1995) 3.30
Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. Int J Food Microbiol (2002) 2.13
Fibrin glue: an effective hemostatic agent for nonsuturable intraoperative bleeding. Ann Thorac Surg (1984) 2.07
Promotion of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci U S A (1989) 1.82
Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res (1997) 1.63
Collagen based dressings--a review. Burns (2000) 1.53
Delivery of molecular medicine to solid tumors. Science (1996) 1.50
Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res (2001) 1.36
Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials (1999) 1.31
Determinants of drug delivery and transport to solid tumors. J Control Release (2001) 1.24
Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials (1999) 1.15
Effects of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro. Biomaterials (1997) 1.12
Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials (2002) 1.11
Applications of chitin and chitosan for biomaterials. Biotechnol Genet Eng Rev (1996) 1.10
Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials (2004) 1.08
Chitosan-mediated stimulation of macrophage function. Biomaterials (1994) 1.07
Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. Biomaterials (2003) 1.03
Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J Biomed Mater Res A (2003) 1.00
Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice. J Control Release (2005) 0.97
Water-soluble chitin as a wound healing accelerator. Biomaterials (1999) 0.97
Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice. Clin Cancer Res (1999) 0.92
Photocrosslinkable chitosan as a biological adhesive. J Biomed Mater Res (2000) 0.92
Experimental evaluation of photocrosslinkable chitosan as a biologic adhesive with surgical applications. Surgery (2001) 0.90
Acceleration of wound healing in healing-impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2. Wound Repair Regen (2005) 0.88
Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations. Biomaterials (2002) 0.87
Inhibition of tumor-induced angiogenesis by sulfated chitin derivatives. Cancer Res (1991) 0.86
Acceleration of wound contraction and healing with a photocrosslinkable chitosan hydrogel. Wound Repair Regen (2002) 0.85
Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model. Wound Repair Regen (2007) 0.84
Localized paclitaxel delivery. Int J Pharm (1999) 0.81
Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J Surg Res (2000) 0.81
Modification of synthesis and investigation of properties for 2-cyanoacrylates. Biomaterials (1990) 0.81
A new biological glue from gelatin and poly (L-glutamic acid). J Biomed Mater Res (1996) 0.80
Cyanoacrylate tissue adhesive for closing skin wounds: a double blind randomized comparison with sutures. Biomaterials (1993) 0.80
Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer: in vivo and in vitro studies. Int J Cancer (1997) 0.78
Inhibitory effect of chitin heparinoids on the lung metastasis of B16-BL6 melanoma. Jpn J Cancer Res (1989) 0.76
Fibrin seal adhesive versus nonabsorbable microsuture in peripheral nerve repair. J Hand Surg Am (1988) 0.76
Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med (2009) 2.25
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet (2008) 2.21
Association of takotsubo cardiomyopathy and long QT syndrome. Circ J (2006) 2.06
Soluble elastin fragments in serum are elevated in acute aortic dissection. Arterioscler Thromb Vasc Biol (2003) 1.96
Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis. Crit Care Med (2002) 1.66
Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart. J Mol Cell Cardiol (2010) 1.64
Sarpogrelate, a specific 5HT2-receptor antagonist, improves the coronary microcirculation in coronary artery disease. Clin Cardiol (2002) 1.50
Enhanced photodynamic cancer treatment by supramolecular nanocarriers charged with dendrimer phthalocyanine. J Control Release (2008) 1.49
Effect of hydrogen gas on the survival rate of mice following global cerebral ischemia. Shock (2012) 1.49
Inhibition of contractile activity during postconditioning enhances cardioprotection by restoring sarcolemmal dystrophin through phosphatidylinositol 3-kinase. Circ J (2010) 1.44
QT peak dispersion, not QT dispersion, is a more useful diagnostic marker for detecting exercise-induced myocardial ischemia. Heart Rhythm (2006) 1.41
Use of near-infrared spectroscopy in combination with monitoring of external jugular vein pressure for early detection of cerebral ischemia by unintentional superior vena cava obstruction. J Cardiothorac Vasc Anesth (2012) 1.39
[End-of-life care in special elderly nursing home for very elderly adults in comparison with emergency palliative therapy in general hospitals]. Nihon Ronen Igakkai Zasshi (2010) 1.39
In vitro study of the optimum volume ratio of activator to adhesive in gelatin-resorcin-formalin glue. Gen Thorac Cardiovasc Surg (2011) 1.39
Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing-impaired wound dressings. Biomaterials (2009) 1.34
Novel lymphography using indocyanine green dye for near-infrared fluorescence labeling. Ann Plast Surg (2007) 1.30
Biodegradation of bisphenol A, bisphenol F and bisphenol S in seawater. Int J Environ Res Public Health (2009) 1.26
Intraoperative lymphography using indocyanine green dye for near-infrared fluorescence labeling in lymphedema. Ann Plast Surg (2007) 1.25
Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients. J Am Heart Assoc (2013) 1.24
Significance of lymphatic invasion and cancer invasion-related proteins on lymph node metastasis in gastric cancer. J Gastroenterol Hepatol (2009) 1.22
An experimental study of the regeneration of the intervertebral disc with an allograft of cultured annulus fibrosus cells using a tissue-engineering method. Spine (Phila Pa 1976) (2003) 1.20
Osteogenic potential of human adipose tissue-derived stromal cells as an alternative stem cell source. Cells Tissues Organs (2004) 1.18
Accelerated wound healing in healing-impaired db/db mice by autologous adipose tissue-derived stromal cells combined with atelocollagen matrix. Ann Plast Surg (2009) 1.16
Bone formation using human adipose tissue-derived stromal cells and a biodegradable scaffold. J Biomed Mater Res B Appl Biomater (2006) 1.14
Retrospective cohort study between selective and standard C3-7 laminoplasty. Minimum 2-year follow-up study. Eur Spine J (2007) 1.11
Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials (2002) 1.11
Effects of music therapy on autonomic nervous system activity, incidence of heart failure events, and plasma cytokine and catecholamine levels in elderly patients with cerebrovascular disease and dementia. Int Heart J (2009) 1.11
Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8. JAMA (2009) 1.10
Discrimination between normal and malignant human gastric tissues by Fourier transform infrared spectroscopy. Cancer Detect Prev (2004) 1.09
Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials (2004) 1.08
Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung. Cancer (2006) 1.06
Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation (2012) 1.06
Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization. J Biomed Mater Res A (2009) 1.05
Bacillus selenatarsenatis sp. nov., a selenate- and arsenate-reducing bacterium isolated from the effluent drain of a glass-manufacturing plant. Int J Syst Evol Microbiol (2007) 1.03
Medium (DMEM/F12)-containing chitosan hydrogel as adhesive and dressing in autologous skin grafts and accelerator in the healing process. J Biomed Mater Res B Appl Biomater (2006) 1.03
Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am J Hypertens (2011) 1.03
Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. Biomaterials (2003) 1.03
Detection of skin perforators by indocyanine green fluorescence nearly infrared angiography. Plast Reconstr Surg (2008) 1.01
Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. Thromb Res (2003) 1.00
Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J Biomed Mater Res A (2003) 1.00
Non-contact respiratory monitoring system using a ceiling-attached microwave antenna. Med Biol Eng Comput (2006) 0.99
Acute toxicity, mutagenicity, and estrogenicity of bisphenol-A and other bisphenols. Environ Toxicol (2002) 0.99
Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice. J Control Release (2005) 0.97
[A Case of Repetitive Cardiac Arrest due to Coronary Vasospasm after Sugammadex Administration]. Masui (2015) 0.97
Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization. J Biomed Mater Res A (2008) 0.96
Targeted increase in cerebral blood flow by transcranial near-infrared laser irradiation. Lasers Surg Med (2010) 0.96
Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization. J Biomed Mater Res A (2006) 0.96
Enhanced healing of mitomycin C-treated wounds in rats using inbred adipose tissue-derived stromal cells within an atelocollagen matrix. Wound Repair Regen (2007) 0.96
Influence of intra-articular neutrophils on the effects of photodynamic therapy for murine MRSA arthritis. Photochem Photobiol (2009) 0.95
The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation. Biomaterials (2005) 0.94
Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv Drug Deliv Rev (2009) 0.94
GROα promotes invasion of colorectal cancer cells. Oncol Rep (2010) 0.93
Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity. Cancer (2004) 0.93